MAPT and Alzheimer disease: Among these compounds, identified by Saitoh et al.,119 (S)‐9b and (S)‐9c orally administered to mice significantly inhibited cold water stress‐induced tau hyperphosphorylation in the brain of mice and improved cognitive behavior of mice and may be potential drugs for AD treatment.